Treatment Approaches to Mycobacterium abscessus Pulmonary Disease
Authors:
- 13 August 2023
- journal article
- research article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 44 (4) , 785-798
Abstract
No abstract availableKeywords
Funding Information
- Mount Sylvia Diatomite
This publication has 94 references indexed in Scilit:
- In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial DiseaseAntimicrobial Agents and Chemotherapy, 2012
- Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?Infection, Genetics and Evolution, 2012
- Mycobacterium abscessus: a new antibiotic nightmareJournal of Antimicrobial Chemotherapy, 2012
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary DiseaseClinical Infectious Diseases, 2011
- Antibiotic Treatment of Mycobacterium abscessus Lung Disease: A Retrospective Analysis of 65 PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2009
- A Novel Gene,erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates ofMycobacterium abscessusbut Is Absent fromMycobacterium chelonaeAntimicrobial Agents and Chemotherapy, 2009
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 2004
- Activities of Linezolid against Rapidly Growing MycobacteriaAntimicrobial Agents and Chemotherapy, 2001
- A Single 16S Ribosomal RNA Substitution Is Responsible for Resistance to Amikacin and Other 2‐Deoxystreptamine Aminoglycosides inMycobacterium abscessusandMycobacterium chelonaeThe Journal of Infectious Diseases, 1998